Literature DB >> 19023553

[Neurological complications of HIV infection].

G Arendt1, T Nolting.   

Abstract

After the introduction of highly active antiretroviral therapy (HAART) in the treatment of HIV (human immunodeficiency virus) infection in 1996, neurological complications of this worldwide infectious disease declined in incidence and prevalence. During the following years however, prevalence and finally also incidence, especially of HIV-associated dementia and its precursor stages, rose again. Nowadays neurologists are confronted with HIV-associated neurocognitive disorders, depression, polyneuropathies and muscle disease, opportunistic brain infections (toxoplasmosis, cryptococcosis, cytomegalovirus infection, progressive multifocal leucoencephalopathy), rising rates of neurosyphilis, and the so-called immune reconstitution syndrome which therefore are topics of this review.

Entities:  

Mesh:

Year:  2008        PMID: 19023553     DOI: 10.1007/s00115-008-2588-x

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  32 in total

1.  HIV related opportunistic infections: still relevant after 25 years of AIDS progress.

Authors:  Joseph Kovacs; Henry Masur
Journal:  Enferm Infecc Microbiol Clin       Date:  2008 Jun-Jul       Impact factor: 1.731

2.  Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. Neurologic complications of HIV disease and their treatment.

Authors:  Scott Letendre; J Allen McCutchan; Ronald J Ellis
Journal:  Top HIV Med       Date:  2008 Apr-May

Review 3.  Pathways to neuronal injury and apoptosis in HIV-associated dementia.

Authors:  M Kaul; G A Garden; S A Lipton
Journal:  Nature       Date:  2001-04-19       Impact factor: 49.962

4.  Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up.

Authors:  T Gibbie; A Mijch; S Ellen; J Hoy; C Hutchison; E Wright; P Chua; F Judd
Journal:  HIV Med       Date:  2006-03       Impact factor: 3.180

5.  Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources.

Authors:  R J Ellis; A C Gamst; E Capparelli; S A Spector; K Hsia; T Wolfson; I Abramson; I Grant; J A McCutchan
Journal:  Neurology       Date:  2000-02-22       Impact factor: 9.910

6.  Effects of antiretroviral treatment on blood-brain barrier integrity and intrathecal immunoglobulin production in neuroasymptomatic HIV-1-infected patients.

Authors:  S Abdulle; L Hagberg; M Gisslén
Journal:  HIV Med       Date:  2005-05       Impact factor: 3.180

7.  PCR detection of Toxoplasma gondii DNA in CSF for the differential diagnosis of AIDS-related focal brain lesions.

Authors:  A Cingolani; A De Luca; A Ammassari; R Murri; A Linzalone; R Grillo; A Antinori
Journal:  J Med Microbiol       Date:  1996-12       Impact factor: 2.472

8.  Neurosyphilis in HIV-infected patients: clinical manifestations, serum venereal disease research laboratory titers, and associated factors to symptomatic neurosyphilis.

Authors:  Rodolfo Poliseli; Jose E Vidal; Augusto C Penalva De Oliveira; Adrian V Hernandez
Journal:  Sex Transm Dis       Date:  2008-05       Impact factor: 2.830

Review 9.  Effects of antiretroviral therapy on cognitive impairment.

Authors:  Kevin J Liner; Colin D Hall; Kevin R Robertson
Journal:  Curr HIV/AIDS Rep       Date:  2008-05       Impact factor: 5.071

10.  Intrathecal viral replication and cerebral deficits in different stages of human immunodeficiency virus disease.

Authors:  Gabriele Arendt; Thorsten Nolting; Christian Frisch; Ingo-Wilhelm Husstedt; Nora Gregor; Eleni Koutsilieri; Mattias Maschke; Alexander Angerer; Mark Obermann; Eva Neuen-Jacob; Ortwin Adams; Sabine Loeffert; Peter Riederer; Volker ter Meulen; Sieghart Sopper
Journal:  J Neurovirol       Date:  2007-06       Impact factor: 2.643

View more
  1 in total

Review 1.  [Demyelinating disorders].

Authors:  T Weber; W Köhler
Journal:  Nervenarzt       Date:  2010-04       Impact factor: 1.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.